NCT02488057 Improving Beta Cell Function in Mexican American Women With Prediabetes Status COMPLETED Phase PHASE4
NCT02473809 The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function Status COMPLETED Phase PHASE4
NCT02472717 Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study Status WITHDRAWN Phase PHASE2
NCT02461589 Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT02453711 Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02443155 A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function Status COMPLETED Phase PHASE2
NCT02408705 Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects Status COMPLETED Phase PHASE2
NCT02403284 The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans Status COMPLETED Phase PHASE4
NCT02344186 Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes Status UNKNOWN Phase PHASE4
NCT02324842 Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients Status COMPLETED Phase NA
NCT02321878 Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®) Status COMPLETED Phase N/A
NCT02315001 Liraglutide to Improve corONary Haemodynamics During Exercise streSS Status COMPLETED Phase PHASE2
NCT02292290 Trial for People With Established Type 2 Diabetes During Ramadan Status COMPLETED Phase PHASE4
NCT02284230 The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure Status WITHDRAWN Phase PHASE2
NCT02255266 Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice Status COMPLETED Phase N/A
NCT02235961 Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02231658 Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion Status TERMINATED Phase PHASE1
NCT02207348 Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors Status COMPLETED Phase PHASE1